2016
DOI: 10.1038/srep39709
|View full text |Cite
|
Sign up to set email alerts
|

The pan-cancer pathological regulatory landscape

Abstract: Dysregulation of the normal gene expression program is the cause of a broad range of diseases, including cancer. Detecting the specific perturbed regulators that have an effect on the generation and the development of the disease is crucial for understanding the disease mechanism and for taking decisions on efficient preventive and curative therapies. Moreover, detecting such perturbations at the patient level is even more important from the perspective of personalized medicine. We applied the Transcription Fa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
34
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(36 citation statements)
references
References 81 publications
2
34
0
Order By: Relevance
“…Inference of TF activities from the expression levels of their putative targets is becoming a widespread tool to extract functional insight from transcriptomic data [2][3][4][5][6][7]69 . Although several strategies exist to define the TF' targets (i.e.…”
Section: Discussionmentioning
confidence: 99%
“…Inference of TF activities from the expression levels of their putative targets is becoming a widespread tool to extract functional insight from transcriptomic data [2][3][4][5][6][7]69 . Although several strategies exist to define the TF' targets (i.e.…”
Section: Discussionmentioning
confidence: 99%
“…TFs activities derived from gene expression data have attracted much attention in cancer research during the last few years. Recent studies have applied DNA-binding networks derived from ENCODE ChIP-Seq data to compare TF activity profiles across different cancers and evaluate their potential as prognostic markers [11,12] . Alternative approaches have estimated protein activities using tumor-specific inferred gene networks and applied them to characterise the impact of somatic alterations [8,9] , proposing new hypotheses on how specific driver mutations may alter transcriptional regulators.…”
Section: Discussionmentioning
confidence: 99%
“…Different from driver alterations in intracellular kinase-mediated signalling cascades, where redundancy may bypass the driver or provide compensatory mechanisms, aberrant transcriptional regulators have been argued to be harder to circumvent by secondary genomic alterations [7] . Consequently, TFs have been proposed as key nodal oncogenic drivers and their activity patterns used to characterise genomic aberrations in cancer [8][9][10] or their influence in a patient's prognosis [11,12] .…”
Section: Introductionmentioning
confidence: 99%
“…The variant overlapped a MYC:MAX heterodimer motif, the MYC:MAC dimer is crucial for binding of MYC to the TF binding site (41). Both MYC and MYC:MAX are known as oncogenes in many cancer types, including breast cancer (42)(43)(44). Genes: ATP6AP1L, ATG10 and RPS23 were found affected by the candidate SNPs.…”
Section: Enrichment Of Genetic Variantsmentioning
confidence: 99%